Meteorologist Jeriann Ritter Saw a Dentist for 'Weird' Feeling in Mouth. It Was 1st Sign of ALS

Jeriann Ritter has spent more than 20 years as the meteorologist for WHO 13, a local NBC affiliate in Des Moines, Iowa.

NBC meteorologist Jeriann Ritter reveals ALS diagnosis

Meteorologist Jeriann Ritter, who works for NBC affiliate WHO 13, revealed she's been tentatively diagnosed with bulbar ...

Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA Conference

Building on the recent U.S. FDA Fast Track Designation for AJ201 (Rosolutamide) and encouraging Phase 2 clinical results, AnnJi presented two scientific abstracts spanning translational transcriptomic ...

What is bulbar ALS? WHO 13's Jeriann Ritter shares likely diagnosis

Amyotrophic lateral sclerosis, or ALS, is a rare nervous system disease. Here's what we know about bulbar ALS, which WHO's Jeriann Ritter may have.

‘If the doctors are right, I’m probably done telling you about the weather. But I still have a lot to say.’ WHO 13’s Jeriann Ritter opens up about her health journey

WHO 13’s Jeriann Ritter opened up about her diagnosis with bulbar ALS in a conversation with Keith Murphy. They talked about what bulbar ALS is, what symptoms she had that led to her ...

‘If the doctors are right, I’m probably done telling you about the weather’: Local weather reporter reveals ALS diagnosis on air

I can tell you, up until this point, I didn’t forecast this storm hitting,’ meteorologist Jeriann Ritter said in an interview ...
Healio

EMA grants orphan drug designation to spinal and bulbar muscular atrophy drug

Please provide your email address to receive an email when new articles are posted on . The European Medicines Agency has granted orphan drug designation to a small molecule intended to treat spinal ...
Yahoo Finance

Nido Biosciences Announces Publication of Collaborative Research Revealing Clinically Meaningful Endpoints for Spinal and Bulbar Muscular Atrophy

BOSTON, December 04, 2024--(BUSINESS WIRE)--Nido Biosciences (Nido Bio), a clinical stage company developing precision medicines for debilitating neurological diseases, today announced a new ...
The American Journal of Managed Care

Disease-Modifying Treatment of Amyotrophic Lateral Sclerosis

Currently, there is no cure for amyotrophic lateral sclerosis (ALS) and the foundation of ALS management revolves around symptomatic and palliative care. Early diagnosis offers the best prognosis for ...